Product
Budesonide/Formoterol
3 clinical trials
3 indications
Indication
AsthmaIndication
Non-adherenceIndication
MedicationClinical trial
A 12-Week Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX(R) 160/4.5 mcg Inhalation Powder Versus SYMBICORT(R) TURBOHALER(R) 200/6 mcg in Adult and Adolescent Patients With Persistent AsthmaStatus: Completed, Estimated PCD: 2014-03-20
Clinical trial
Symptom-driven Combination Inhaled Corticosteroids and Long-acting Beta Agonist Therapy for Patients With Asthma Who Are Identified as Non-adherent to Daily Maintenance InhalersStatus: Recruiting, Estimated PCD: 2023-11-30
Clinical trial
Expertise Asthma COPD Program With Digital SupportStatus: Recruiting, Estimated PCD: 2025-01-31